These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11400745)

  • 1. Pilot neonatal screening program for lysosomal storage disorders, using lamp-1.
    Ranierri E; Gerace RL; Ravenscroft EM; Hopwood JJ; Meikle PJ
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():111-3. PubMed ID: 11400745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for lysosomal storage disorders.
    Meikle PJ; Ranieri E; Ravenscroft EM; Hua CT; Brooks DA; Hopwood JJ
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():104-10. PubMed ID: 11400743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy.
    Meikle PJ; Ranieri E; Simonsen H; Rozaklis T; Ramsay SL; Whitfield PD; Fuller M; Christensen E; Skovby F; Hopwood JJ
    Pediatrics; 2004 Oct; 114(4):909-16. PubMed ID: 15466084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker.
    Meikle PJ; Brooks DA; Ravenscroft EM; Yan M; Williams RE; Jaunzems AE; Chataway TK; Karageorgos LE; Davey RC; Boulter CD; Carlsson SR; Hopwood JJ
    Clin Chem; 1997 Aug; 43(8 Pt 1):1325-35. PubMed ID: 9267309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the lysosome-associated membrane protein LAMP-2 as a marker for lysosomal storage disorders.
    Hua CT; Hopwood JJ; Carlsson SR; Harris RJ; Meikle PJ
    Clin Chem; 1998 Oct; 44(10):2094-102. PubMed ID: 9761240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal biogenesis in lysosomal storage disorders.
    Karageorgos LE; Isaac EL; Brooks DA; Ravenscroft EM; Davey R; Hopwood JJ; Meikle PJ
    Exp Cell Res; 1997 Jul; 234(1):85-97. PubMed ID: 9223373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lysosomal granule membrane protein, LAMP-2, is also present in platelet dense granule membranes.
    Israels SJ; McMillan EM; Robertson C; Singhory S; McNicol A
    Thromb Haemost; 1996 Apr; 75(4):623-9. PubMed ID: 8743190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for lysosomal storage disorders.
    Meikle PJ; Grasby DJ; Dean CJ; Lang DL; Bockmann M; Whittle AM; Fietz MJ; Simonsen H; Fuller M; Brooks DA; Hopwood JJ
    Mol Genet Metab; 2006 Aug; 88(4):307-14. PubMed ID: 16600651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the lysosome-associated membrane protein in a sucrose model of lysosomal storage.
    Isaac EL; Karageorgos LE; Brooks DA; Hopwood JJ; Meikle PJ
    Exp Cell Res; 2000 Feb; 254(2):204-9. PubMed ID: 10640418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases.
    Ramsay SL; Maire I; Bindloss C; Fuller M; Whitfield PD; Piraud M; Hopwood JJ; Meikle PJ
    Mol Genet Metab; 2004 Nov; 83(3):231-8. PubMed ID: 15542394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I.
    Magera MJ; Gunawardena ND; Hahn SH; Tortorelli S; Mitchell GA; Goodman SI; Rinaldo P; Matern D
    Mol Genet Metab; 2006 May; 88(1):16-21. PubMed ID: 16448836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preparation and storage of dried-blood spot quality control materials for lysosomal storage disease screening tests.
    Adam BW; Orsini JJ; Martin M; Hall EM; Zobel SD; Caggana M; Hannon WH
    Clin Biochem; 2011 Jun; 44(8-9):704-10. PubMed ID: 21382365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
    Hopkins PV; Campbell C; Klug T; Rogers S; Raburn-Miller J; Kiesling J
    J Pediatr; 2015 Jan; 166(1):172-7. PubMed ID: 25444528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saposins A, B, C, and D in plasma of patients with lysosomal storage disorders.
    Chang MH; Bindloss CA; Grabowski GA; Qi X; Winchester B; Hopwood JJ; Meikle PJ
    Clin Chem; 2000 Feb; 46(2):167-74. PubMed ID: 10657372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered trafficking and turnover of LAMP-1 in Pompe disease-affected cells.
    Meikle PJ; Yan M; Ravenscroft EM; Isaac EL; Hopwood JJ; Brooks DA
    Mol Genet Metab; 1999 Mar; 66(3):179-88. PubMed ID: 10066386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening patients referred to a metabolic clinic for lysosomal storage disorders.
    Fuller M; Tucker JN; Lang DL; Dean CJ; Fietz MJ; Meikle PJ; Hopwood JJ
    J Med Genet; 2011 Jun; 48(6):422-5. PubMed ID: 21415080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First pilot newborn screening for four lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene.
    Paciotti S; Persichetti E; Pagliardini S; Deganuto M; Rosano C; Balducci C; Codini M; Filocamo M; Menghini AR; Pagliardini V; Pasqui S; Bembi B; Dardis A; Beccari T
    Clin Chim Acta; 2012 Nov; 413(23-24):1827-31. PubMed ID: 22820396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for lysosomal storage disorders.
    Matern D; Gavrilov D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
    Semin Perinatol; 2015 Apr; 39(3):206-16. PubMed ID: 25891428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.
    Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders.
    De Jesus VR; Zhang XK; Keutzer J; Bodamer OA; Mühl A; Orsini JJ; Caggana M; Vogt RF; Hannon WH
    Clin Chem; 2009 Jan; 55(1):158-64. PubMed ID: 18988750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.